Patient self-report for evaluating mild cognitive impairment and prodromal Alzheimer's disease
Patient-reported outcome (PRO) measures are used to evaluate disease and treatments in many therapeutic areas, capturing relevant aspects of the disorder not obtainable through clinician or informant report, including those for which patients may have a greater level of awareness than those around t...
Main Authors: | Frank, Lori, Lenderking, William R, Howard, Kellee, Cantillon, Marc |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308024/ |
Similar Items
-
Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease
by: Karakaya, Tarik, et al.
Published: (2013) -
Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
by: Chalermpalanupap, Termpanit, et al.
Published: (2013) -
Writing Impairments in Japanese Patients with Mild Cognitive Impairment and with Mild Alzheimer's Disease
by: Hayashi, Atsuko, et al.
Published: (2015) -
Amyloid imaging in prodromal Alzheimer's disease
by: Ossenkoppele, Rik, et al.
Published: (2011) -
Automatic morphometry in Alzheimer's disease and mild cognitive impairment☆☆☆
by: Heckemann, Rolf A., et al.
Published: (2011)